tirzepatide patent court decision on Judge says compounding pharmacies must stop making copies of Zepbound, Mounjaro Semaglutide & Tirzepatide Tirzepatide | US Patents |

The 8 to 12 week window often marks a shift into more consistent weekly weight loss, with patients averaging 1 to 2 pounds per week as appetite suppression deepens and behavioral changes solidify

By using risk-based protocols, data tracking, and support teams to guide prescribing and outreach efforts

Yes, an unopened, factory-sealed vial is sterile and stable at room temperature during shipping

Following GLP-1 deprescription, patients weight did not significantly increase at 6 or 12 months post deprescription, compared to many well-known drug trials (in red) where patients regain up to two thirds of weight loss after discontinuing the drug

Why it matters: For patients with chronic joint pain, tendonitis, gut inflammation, or post-surgical inflammation, this means less swelling, better circulation, and faster repair